The HR+/HER2− BC has been shown to have an increased level of expression of the estrogen receptor 1 gene (ESR1), and CCND1 gene (encodes cyclin D1), which results in cell cycle progression through phosphorylation and inactivation of the Rb protein. The gene discussed is CCND1; the disease is breast cancer.